Inventor · disambiguated record
Boris Kroeplien
Also filed as: KROEPLIEN BORIS
26 granted patents·3 pending applications·113 citations·filing 2013–2024
95Inventor score
Top patents by PatentIndex Score
29 records- 0196US10705094B2TNF receptor signaling modulator assayUCB Biopharma SRL·Filed 2015·Granted Jul 7, 2020·9 cites·18 claims
- 0295US10883996B2Methods of identifying signaling modulators of the trimeric TNFaUCB Biopharma SRL·Filed 2015·Granted Jan 5, 2021·7 cites·5 claims
- 0393US11448655B2Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptorsUCB Biopharma SRL·Filed 2020·Granted Sep 20, 2022·2 cites·17 claims
- 0493US10775385B2Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimersUCB BIOPHARMA SPRL·Filed 2015·Granted Sep 15, 2020·7 cites·4 claims
- 0592US11674967B2Method of identifying potential inhibitors of APO TNFα trimersUCB Biopharma SRL·Filed 2020·Granted Jun 13, 2023·2 cites·19 claims
- 0689US9969728B2Tetrahydroimidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted May 15, 2018·14 cites·7 claims
- 0789US2025012807A1Mechanism of actionUCB Biopharma SRL·Filed 2024·Application pending·0 cites
- 0887US9868749B2Fused imidazole and pyrazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jan 16, 2018·16 cites·7 claims
- 0985US12474348B2Complexes between CD40 and compounds comprising benzimidazole moietiesUCB Biopharma SRL·Filed 2022·Granted Nov 18, 2025·0 cites·6 claims
- 1085US9873703B2Imidazopyridazine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jan 23, 2018·8 cites·8 claims
- 1184US10087179B2Fused tricyclic imidazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Oct 2, 2018·8 cites·11 claims
- 1284US9932343B2Fused tricyclic benzimidazoles derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Apr 3, 2018·10 cites·16 claims
- 1383US9890174B2Fused Tricyclic imidazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Feb 13, 2018·8 cites·16 claims
- 1477US9550737B2TNF -α modulating benzimidazolesUCB BIOPHARMA SPRL·Filed 2013·Granted Jan 24, 2017·4 cites·10 claims
- 1577US2021140972A1Mechanism of actionUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 1675US9309243B2Imidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2013·Granted Apr 12, 2016·4 cites·11 claims
- 1774US9926313B2Imidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Mar 27, 2018·2 cites·8 claims
- 1871US9815797B2Fused bicyclic heteroaromatic derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Nov 14, 2017·2 cites·8 claims
- 1970US9890154B2Imidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Feb 13, 2018·1 cites·5 claims
- 2069US10093652B2Tetrahydrobenzimidazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Oct 9, 2018·1 cites·5 claims
- 2169US9988383B2Purine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jun 5, 2018·1 cites·6 claims
- 2269US9957255B2Benzotriazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted May 1, 2018·1 cites·8 claims
- 2369US9932342B2Imidazopyrimidine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Apr 3, 2018·1 cites·6 claims
- 2469US9902720B2Pyrazolopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Feb 27, 2018·1 cites·6 claims
- 2569US9834553B2Tetrahydroimidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Dec 5, 2017·1 cites·5 claims
- 2668US10004737B2Fused imidazole and pyrazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jun 26, 2018·1 cites·8 claims
- 2768US9932334B2Tetrahydroimidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Apr 3, 2018·1 cites·5 claims
- 2865US10287299B2Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activityUCB BIOPHARMA SPRL·Filed 2016·Granted May 14, 2019·1 cites·6 claims
- 2936US2018222868A1Indazole Derivatives as Modulators of TNF ActivityUCB BIOPHARMA SPRL·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Boris Kroeplien files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →